Antibodies: Timeline of key events
Mouseover the event title for a more detailed description of the event (if available). To search for particular terms in the description of the event enter the term in the box below 'Event' on the table and press 'enter'. Alternatively use the dropdown lists to filter by Person, Place or Science. Click here to clear the filter.
|23 Dec 2019||Seattle Genetics submitted New Drug Application to FDA for testing tucatinib in patients with locally advanced or metatastic HER2-positive breast cancer||Seattle Genetics||Monoclonal antibodies, Oncology|